Nkarta Q1 net loss $30.8M, cash $332.1M, CFO resigning

Nkarta, Inc.

2023-Q1 EPS reported -$0.63

Net loss of $30.8M ($0.63 per share) for Q1 2023; R&D expenses $26.1M, G&A $8.2M.
Cash and equivalents $332.1M as of March 31, 2023; runway expected into 2025.
CFO Nadir Mahmood resigning effective June 30, 2023; successor search underway.
NKX101 clinical update planned for Q2 2023; NKX019 update in H2 2023.
Preclinical data on NK cell engineering presented at AACR 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Nkarta, Inc. reported for the first quarter ended March 31, 2023 results: net income $30.8 million, EPS $0.63 per basic and diluted share. Guidance initiated.

Period: for the first quarter ended March 31, 2023
Net income: $30.8 million
EPS: $0.63 per basic and diluted share
Guidance: initiated
Result: reported results

Exact text from the filing

Net loss was $30.8 million, or $0.63 per basic and diluted share, for the first quarter of 2023.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Nkarta, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-021218

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.